Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Israel / NCT07334639
Starting soon Observational

Metabolic Changes Associated With Weight Gain After Treatment of Achalasia

NCT07334639 · tracked via the Priya Life Science Israel tracker
Sponsor
Assaf-Harofeh Medical Center
Phase
Observational
Started
2026-01-15
Last updated
2026-01-13

Condition(s) studied

Achalasia, Esophageal

Study summary

This goal of the study is to assess the effect of weight gain in patients with achalasia after they are treated. The main question to be answered is if weight gain after achalasia treatment is associated with worsening metabolic status. Patients will be compared between their baseline status at the time of treatment and 1 year after treatment. Participants will have metabolic tests performed at these 2 times including blood tests.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Proven achalasia * Undergoing LHM or POEM for treatment Exclusion Criteria: * Under age 18 * Does no consent

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Hadassah Medical Center Jerusalem Israel
Shamir Medical Center Ẕerifin Israel

More Assaf-Harofeh Medical Center trials in Israel

Effect of Hyperoxygenated Environment on Maximal Muscle Strength Recruiting
Sensory Rehabilitation in Chemo Induced Peripheral Neuropathy Recruiting
Hyperbaric Oxygen Therapy Used on Severely Injured Healthy Individuals With Fungal Infections Active, not recruiting
Tranexamic Acid During Colonic Endoscopic Resection Procedures Recruiting
Cognitive Profile of Patients at the Sagol Center for Hyperbaric Medicine and Research Active, not recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07334639 on ClinicalTrials.gov ↗ ← All trials in Israel